Line 12: | Line 12: | ||
overflow:hidden; | overflow:hidden; | ||
background-size: cover; | background-size: cover; | ||
− | + | position:relative; | |
/*min-height: 100%; | /*min-height: 100%; | ||
display:flex; | display:flex; | ||
Line 27: | Line 27: | ||
.insubiota-subtext { font:2em caviardreams, sans-serif; text-align: center; color:white } | .insubiota-subtext { font:2em caviardreams, sans-serif; text-align: center; color:white } | ||
+ | |||
+ | #titleinsubiota { | ||
+ | position: absolute; | ||
+ | top: 0; | ||
+ | bottom: 0; | ||
+ | left: 0; | ||
+ | right: 0; | ||
+ | width: 50%; | ||
+ | height: 30%; | ||
+ | margin: auto; | ||
+ | } | ||
</style> | </style> | ||
Line 33: | Line 44: | ||
<div class="foto-grande"> | <div class="foto-grande"> | ||
− | <div | + | <div id="titleinsubiota"> |
<div class="insubiota-text">INSUBIOTA</div> | <div class="insubiota-text">INSUBIOTA</div> | ||
<div class="insubiota-subtext">treating diabetes with genetically engineered probiotic</div> | <div class="insubiota-subtext">treating diabetes with genetically engineered probiotic</div> |
Revision as of 14:03, 1 November 2017
iGEM AQA_Unesp
INSUBIOTA
treating diabetes with genetically engineered probiotic